Cargando…
Patient-derived organoid (PDO) platforms to facilitate clinical decision making
Based on recent advances in organoid research as well as the need to find more accurate models for drug screening in cancer research, patient-derived organoids have emerged as an effective in vitro model system to study cancer. Showing numerous advantages over 2D cell lines, 3D cell lines, and prima...
Autores principales: | Liu, Lisa, Yu, Lei, Li, Zhichao, Li, Wujiao, Huang, WeiRen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821720/ https://www.ncbi.nlm.nih.gov/pubmed/33478472 http://dx.doi.org/10.1186/s12967-020-02677-2 |
Ejemplares similares
-
Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
por: Chitrangi, Swati, et al.
Publicado: (2023) -
Correction: Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
por: Chitrangi, Swati, et al.
Publicado: (2023) -
Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening
por: Li, Zhichao, et al.
Publicado: (2020) -
Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitro
por: Yu, Lei, et al.
Publicado: (2021) -
Protocol for generation of lung adenocarcinoma organoids from clinical samples
por: Li, Zhichao, et al.
Publicado: (2020)